{"log_id": 5777231163981378192, "direction": 0, "words_result_num": 41, "words_result": [{"probability": {"variance": 0.004025, "average": 0.980805, "min": 0.607289}, "location": {"width": 765, "top": 213, "height": 30, "left": 210}, "words": "中,其产生自杀观念的平均风险为0.4%(5/1357患者),而使用安慰剂治疗的患者没有这"}, {"probability": {"variance": 0.003417, "average": 0.988063, "min": 0.626599}, "location": {"width": 746, "top": 253, "height": 26, "left": 230}, "words": "风险:在这些约2200名患者中,有1名使用盐酸托莫西汀胶囊的患者出现自杀企图。但"}, {"probability": {"variance": 2e-06, "average": 0.999062, "min": 0.993898}, "location": {"width": 766, "top": 291, "height": 26, "left": 211}, "words": "在所有的试验中没有自杀事件的发生。所有的事件均发生在12岁及以下的儿童、治疗的第"}, {"probability": {"variance": 0.000121, "average": 0.996343, "min": 0.938078}, "location": {"width": 725, "top": 329, "height": 26, "left": 235}, "words": "个月内。在儿科患者中产生自杀观念风险的结论是否可以推广到长期使用中还不清楚"}, {"probability": {"variance": 3.5e-05, "average": 0.996399, "min": 0.973468}, "location": {"width": 743, "top": 366, "height": 27, "left": 234}, "words": "个相似的分析在使用盐酸托莫西汀胶囊治疗ADHD或重性抑郁障碍(MDD)患者中进"}, {"probability": {"variance": 5.8e-05, "average": 0.99695, "min": 0.964952}, "location": {"width": 678, "top": 406, "height": 26, "left": 210}, "words": "行,并没有发现与盐酸托莫西汀胶囊使用相关的产生自杀观念或行为风险的增加"}, {"probability": {"variance": 0.002454, "average": 0.986485, "min": 0.711446}, "location": {"width": 727, "top": 444, "height": 25, "left": 249}, "words": "所有使用盐酸托莫西汀胶囊治疗的儿科患者应该对其自杀倾向,临床症状的恶化以及"}, {"probability": {"variance": 1.6e-05, "average": 0.998529, "min": 0.979587}, "location": {"width": 761, "top": 482, "height": 26, "left": 209}, "words": "异常的行为改变进行密切的监控,特别是在药物治疗的最初阶段,或在剂量改变的治疗阶"}, {"probability": {"variance": 0.007249, "average": 0.977462, "min": 0.575753}, "location": {"width": 765, "top": 520, "height": 26, "left": 208}, "words": "段,监控通常包括在治疗的最初4周内,与患者或其家庭成员或护理人员进行每周一次的"}, {"probability": {"variance": 4.6e-05, "average": 0.998099, "min": 0.957344}, "location": {"width": 765, "top": 557, "height": 27, "left": 209}, "words": "面对面的联系,随后的4周每周一次的随访,以及第12周和12周以上有临床指征时进行"}, {"probability": {"variance": 4e-05, "average": 0.997395, "min": 0.970492}, "location": {"width": 468, "top": 595, "height": 28, "left": 208}, "words": "随访。通过电话进行的联系可以在面对面随访之间开展"}, {"probability": {"variance": 0.000742, "average": 0.988457, "min": 0.881923}, "location": {"width": 726, "top": 632, "height": 28, "left": 248}, "words": "使用盐酸托莫西汀胶囊治疗后,有报告下列症状包括:焦虑,激越,惊恐发作,失"}, {"probability": {"variance": 5.3e-05, "average": 0.996177, "min": 0.960476}, "location": {"width": 766, "top": 669, "height": 31, "left": 208}, "words": "眠,易激惹,敌意,攻击行为,冲动,静坐不能(精神运动性不安),轻躁狂和躁狂。尽管"}, {"probability": {"variance": 0.000112, "average": 0.997113, "min": 0.93338}, "location": {"width": 766, "top": 707, "height": 32, "left": 208}, "words": "这些症状的出现与自杀冲动出现之间没有因果的关联,但这些症状可能预示自杀观念的出"}, {"probability": {"variance": 6e-06, "average": 0.998506, "min": 0.98841}, "location": {"width": 641, "top": 747, "height": 30, "left": 209}, "words": "现。因此,应该对使用盐酸托莫西汀胶囊治疗的患者出现这些症状进行观察"}, {"probability": {"variance": 2.3e-05, "average": 0.997696, "min": 0.974728}, "location": {"width": 707, "top": 785, "height": 28, "left": 250}, "words": "关注治疗过程中出现的变化,包括患者出现的可能自杀观念或出现自杀观念的先兆"}, {"probability": {"variance": 1.8e-05, "average": 0.998049, "min": 0.979709}, "location": {"width": 763, "top": 821, "height": 30, "left": 210}, "words": "特别是如果症状加重或突然发作,或患者出现现有症状外的症状时,可能需要停止药物的"}, {"probability": {"variance": 2e-06, "average": 0.998564, "min": 0.997194}, "location": {"width": 44, "top": 865, "height": 23, "left": 211}, "words": "使用"}, {"probability": {"variance": 1.8e-05, "average": 0.997382, "min": 0.981891}, "location": {"width": 727, "top": 896, "height": 31, "left": 249}, "words": "接受盐酸托莫西汀胶囊治疗的儿科患者的家庭成员和护理人员应该警惕患者出现激"}, {"probability": {"variance": 2e-06, "average": 0.998671, "min": 0.994018}, "location": {"width": 765, "top": 932, "height": 34, "left": 212}, "words": "越,易激惹,异常的行为改变,以及其他如上描述的症状和自杀观念的出现时对患者实施"}, {"probability": {"variance": 0.024551, "average": 0.935463, "min": 0.376616}, "location": {"width": 756, "top": 966, "height": 36, "left": 212}, "words": "监控,并立即向医疗服务提供者报告这些症状,患者的家庭成员和护理大员在常生"}, {"probability": {"variance": 2e-06, "average": 0.997727, "min": 0.995497}, "location": {"width": 99, "top": 1017, "height": 22, "left": 214}, "words": "中进行观测"}, {"probability": {"variance": 0.050591, "average": 0.801239, "min": 0.421733}, "location": {"width": 167, "top": 1007, "height": 40, "left": 799}, "words": "来贸易"}, {"probability": {"variance": 0.000705, "average": 0.980665, "min": 0.928556}, "location": {"width": 122, "top": 1054, "height": 24, "left": 212}, "words": "严重肝脏损伤"}, {"probability": {"variance": 0.009201, "average": 0.929195, "min": 0.749757}, "location": {"width": 252, "top": 1011, "height": 78, "left": 778}, "words": "有限公司人"}, {"probability": {"variance": 0.028764, "average": 0.923063, "min": 0.357808}, "location": {"width": 759, "top": 1059, "height": 63, "left": 252}, "words": "上市后报告显示盐酸托莫西汀能导致严重肝功能受损。尽管在有70名患者"}, {"probability": {"variance": 0.000238, "average": 0.994871, "min": 0.917446}, "location": {"width": 765, "top": 1121, "height": 34, "left": 213}, "words": "的临床试验中并没有观察到发生肝功能受损的病例,但在上市后经验中出现过极罕见的被"}, {"probability": {"variance": 4.1e-05, "average": 0.997525, "min": 0.970073}, "location": {"width": 765, "top": 1158, "height": 33, "left": 213}, "words": "认为很可能或可能与使用本品有关的且有临床意义的肝损伤病例,已经报告罕见的肝功能"}, {"probability": {"variance": 0.000103, "average": 0.99659, "min": 0.953747}, "location": {"width": 765, "top": 1197, "height": 32, "left": 213}, "words": "衰竭病例,包括1例导致肝移植的病例。由于可能存在“报道不足”的问题,对于此类"}, {"probability": {"variance": 0.01557, "average": 0.955817, "min": 0.423277}, "location": {"width": 763, "top": 1232, "height": 37, "left": 215}, "words": "事件的发生率很难有精确的估计已报告的肝功能受损病例多数发生在开始服用本品"}, {"probability": {"variance": 0.004511, "average": 0.970586, "min": 0.645941}, "location": {"width": 757, "top": 1272, "height": 33, "left": 222}, "words": "20天内,一些患者出现显著的肝酶升高[>20X正常上限(ULN)]及黄疸伴胆红素水平显著"}, {"probability": {"variance": 0.000891, "average": 0.981966, "min": 0.892916}, "location": {"width": 812, "top": 1301, "height": 45, "left": 214}, "words": "升高(>2XULN),并在停药后恢复。其中一名患者出现以肝酶升高达到40倍正常值上限和"}, {"probability": {"variance": 0.009922, "average": 0.97173, "min": 0.377471}, "location": {"width": 841, "top": 1347, "height": 35, "left": 213}, "words": "黄疸伴胆红素升高达12倍正常值上限为显著特征的肝损伤,再次给药后发生相似情况,停医"}, {"probability": {"variance": 0.001229, "average": 0.992002, "min": 0.77906}, "location": {"width": 841, "top": 1384, "height": 32, "left": 213}, "words": "药后的随访期内恢复正常,从而表明可能为盐酸托莫西汀所致。这样的反应可能在开始治公"}, {"probability": {"variance": 0.000653, "average": 0.992637, "min": 0.844348}, "location": {"width": 766, "top": 1422, "height": 33, "left": 214}, "words": "疗后几个月出现,但实验室指标可能在停药后数周内显示持续恶化。上述患者的肝功能均"}, {"probability": {"variance": 0.001527, "average": 0.983216, "min": 0.861018}, "location": {"width": 215, "top": 1466, "height": 23, "left": 215}, "words": "已恢复,没有进行肝移植"}, {"probability": {"variance": 0, "average": 0.97284, "min": 0.97284}, "location": {"width": 130, "top": 1537, "height": 43, "left": 565}, "words": "※"}, {"probability": {"variance": 0.014074, "average": 0.69037, "min": 0.522712}, "location": {"width": 195, "top": 1501, "height": 58, "left": 919}, "words": "礼貿三"}, {"probability": {"variance": 0.011981, "average": 0.593287, "min": 0.48383}, "location": {"width": 131, "top": 1561, "height": 73, "left": 576}, "words": "灌织"}, {"probability": {"variance": 0.008297, "average": 0.935333, "min": 0.806517}, "location": {"width": 176, "top": 1523, "height": 79, "left": 899}, "words": "限公司"}, {"probability": {"variance": 0.000106, "average": 0.98007, "min": 0.966424}, "location": {"width": 96, "top": 1600, "height": 37, "left": 1062}, "words": "叉供存档"}], "language": 3}